Q4 Results Today: 75 Firms, Divi’s Labs Q4FY25 Up

Earnings calendar for May 23: why this day matters

India’s March-quarter reporting season is set for a busy session on May 23, with over 75 listed companies scheduled to announce Q4FY26 results. The lineup spans sectors such as power, cement, pharmaceuticals, infrastructure, specialty chemicals, packaging films, wires and consumer accessories. For investors, clustered result days can drive stock-specific volatility as companies release financials, commentary, and in some cases dividend announcements.

A few widely tracked names expected to report include NTPC, JK Cement, Reliance Infrastructure, Anupam Rasayan India, Dollar Industries, Polyplex Corporation, Precision Wires India, and India Pesticides. Rainbow Children’s Medicare and Studds Accessories are also listed among companies scheduled to announce quarterly numbers.

Key companies expected to announce Q4FY26 results

The day’s result calendar includes several large and mid-cap stocks that can influence sector sentiment. NTPC’s update is watched closely given its role in the power sector. JK Cement’s numbers are tracked for demand trends and cost pressures in cement. Reliance Infrastructure’s results are monitored for the company’s operational and financial position.

In pharmaceuticals, Divi’s Laboratories is a key name on the day’s earnings list, and it also drew attention due to reported quarterly and annual numbers for the year ended March 31, 2025 and a board-recommended dividend. Specialty chemicals firm Anupam Rasayan India is another company on the list, alongside consumer and industrial names such as Dollar Industries, Polyplex Corporation and Precision Wires India.

Full list: firms slated to release results on May 23

The published schedule includes multiple companies, including (among others): Abirami Financial Services India, Advance Multitech, Advance Petrochemicals, Amit Securities, Anjani Foods, Anupam Rasayan India, Ashima, Aspira Pathlab and Diagnostics, Bhudevi Infra Projects, Captain Pipes, Captain Polyplast, Digjam, Divi’s Laboratories, Dollar Industries, India Pesticides, JK Cement, Mawana Sugars, NTPC, Polyplex Corporation, Precision Wires India, Rainbow Children’s Medicare, and Reliance Infrastructure.

A separate schedule excerpt also listed certain result classifications, such as “Audited Results”, and highlighted that Divi’s Laboratories’ update included “Audited Results & Dividend”.

Divi’s Laboratories: reported Q4FY25 and FY25 performance

Divi’s Laboratories reported its results for the quarter ended March 31, 2025 on Saturday, according to the provided update. For Q4, the company’s consolidated net profit was reported at ₹662 crore compared with ₹538 crore a year ago, an increase of 23 percent. The company’s operating performance was also highlighted with EBITDA reported at ₹886 crore, up 21.2 percent year-on-year, with EBITDA margin expansion to 25.6 percent.

On the revenue line, different figures were cited in the provided material. One report stated revenue from operations rose 40.83 percent to ₹2,518.44 crore in the quarter from ₹1,788.19 crore in the same quarter last year. Another update cited revenue from operations at ₹2,585 crore for Q4 versus ₹2,303 crore a year ago, indicating 12 percent growth. In addition, a management-style overview cited consolidated total income of ₹2,671 crore for the quarter versus ₹2,382 crore in the corresponding quarter of the previous year.

Divi’s FY25: income, profit, forex, and business mix disclosures

For the full year 2024-25, the same management-style overview cited consolidated total income of ₹9,712 crore compared with ₹8,184 crore for the previous financial year. It also stated profit before tax (PBT) of ₹2,916 crore versus ₹2,163 crore in the previous year, and profit after tax (PAT) of ₹2,191 crore versus ₹1,600 crore.

The overview also disclosed a forex gain of ₹10 crore in the quarter compared with a forex loss of ₹2 crore in the corresponding quarter last year. For the full year, it cited a forex gain of ₹48 crore versus a gain of ₹30 crore in the prior year. It further stated that material consumption remained at about 40 percent of sales revenue for both the current and previous financial years.

The company also disclosed that its nutraceutical business amounted to ₹781 crore for the financial year and ₹205 crore for the quarter ended March 31, 2025. On capital expenditure and projects, it cited assets capitalised of ₹560 crore during the quarter, including ₹337 crore for the Kakinada project. It also reported capital work-in-progress of ₹1,022 crore as of March 31, 2025, with Kakinada accounting for ₹562 crore.

Dividend and market reaction in Divi’s stock

Alongside the numbers, the company’s board recommended a final dividend of ₹30 per equity share (face value ₹2) for the financial year 2024-25. In market action referenced in the update, Divi’s Laboratories shares were reported to have closed up 4.8 percent at ₹6,580 after the Q4 profit update.

The same update also said Divi’s delivered a “better-than-expected” performance compared with expectations, noting beats on sales, EBITDA and PAT, and that growth was recorded across both custom synthesis (CS) and API segments. These remarks were presented as commentary in the provided material and are best read as context rather than forward guidance.

What to watch across May 23 result-makers

With dozens of results expected on the same day, investor focus typically shifts to (a) headline profit and margin changes, (b) any dividend declarations, and (c) management commentary on demand, pricing, costs, and capacity additions. For companies such as NTPC, investors generally track updates relevant to operational and financial performance. For industrial and consumer names such as JK Cement, Polyplex Corporation, Dollar Industries and Precision Wires India, quarterly commentary can help explain whether performance was driven by volumes, pricing, raw materials, or mix.

For stocks like Divi’s Laboratories, investors often parse the gap between “revenue from operations” and “total income” disclosures and look for clarity in the audited filings, especially when multiple media summaries cite different topline figures. On a crowded results day, the market response can be driven as much by guidance, segment performance and one-offs as by headline quarterly growth.

Key facts table: results day snapshot

Conclusion

May 23 is set to be a packed Q4FY26 earnings day, with over 75 companies scheduled to report, including widely tracked names such as NTPC, JK Cement and Reliance Infrastructure. Divi’s Laboratories remains in focus due to the reported FY25 profitability, disclosures on forex and capex, and the board’s recommended final dividend. Investors will be watching the audited filings and management commentary as results land through the day.